About
David Snitman is a biotech executive and advisor best known as a co-founder of Array BioPharma, where he served from 1998 to 2015 in business-development and operating leadership roles. He previously held senior roles at Amgen, including Associate Director of New Products and Technology and manager of Amgen's Boulder research facility. He is currently listed as principal of DL SNITMAN LLC and serves on the Advisory Board of AmideBio.
Areas of interest
biotechbiopharma business developmentdrug discoveryoncologypeptide therapeuticsmetabolic diseasepharma partnershipslicensing